BackEucrates Biomedical Acquisition Overview

Eucrates Biomedical Acquisition Accounts Payable

Eucrates Biomedical Acquisition's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average

Loading

Eucrates Biomedical Acquisition Accounts Payable History

Loading

Eucrates Biomedical Acquisition vs. peers: Accounts Payable Comparison

Loading

Eucrates Biomedical Acquisition Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Eucrates Biomedical Acquisition (EUCR) FAQ

As of the most recent data (December 2022), EUCR shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCR's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition is outperforming or lagging.

Tracking EUCR's accounts payable over time shows whether Eucrates Biomedical Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Eucrates Biomedical Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.